TC
PTLA

Travelers Companies’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Travelers Companies’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-7,072
Closed -$179K – 34
2014
Q3 		$179K Buy
+7,072
New +$186K 0.04% 25
2014
Q2 		– Sell
-1,782
Closed -$46K – 47
2014
Q1 		$46K Buy
+1,782
New +$47.6K 0.01% 42

Other funds holding PTLA

Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Travelers Companies's PTLA Position: Q4 2014 in Review

Travelers Companies sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2014, closing a stake of 7,072 shares — an estimated $179K sold.

Travelers Companies first reported a position in PTLA in Q1 2014 and held it in 2 quarters. The position peaked at $179K in Q3 2014. 133 funds tracked by Wall St. Rank hold PTLA as of Q4 2014.

  • Travelers Companies reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Travelers Companies sold 7,072 Portola Pharmaceuticals, Inc. shares in Q4 2014, an estimated $179K.
  • Travelers Companies first reported a position in Portola Pharmaceuticals, Inc. in Q1 2014 and held it in 2 quarters.
  • Travelers Companies's Portola Pharmaceuticals, Inc. position peaked at $179K in Q3 2014.
  • 133 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2014.

Based on Travelers Companies's 13F filing for Q4 2014, filed 12 Feb 2015.